Evidence map›Paper›PMID 40104474›Full record

ArticleCureus2025

A Comparison of Postmortem Serum and Pericardial Fluid Total Bilirubin Levels With Antemortem Data.

Shojiro Takasu, Sari Matsumoto, Kana Sakamoto

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. PMI estimation throughMetabolomics : Official journal of the Metabolomic Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shojiro TakasuDepartment of Forensic Medicine, The Jikei University School of Medicine, Tokyo, JPN.
Sari MatsumotoDepartment of Forensic Medicine, The Jikei University School of Medicine, Tokyo, JPN.
Kana SakamotoDepartment of Forensic Medicine, The Jikei University School of Medicine, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe accuracy of total bilirubin (T-Bil) measurement in postmortem specimens is unclear because most forensic autopsy cases lack recent antemortem biochemical data to serve as references. MATERIALS AND

methodsThis study compared T-Bil concentrations between antemortem serum values, postmortem serum, and pericardial fluid values in 37 forensic autopsy cases (postmortem interval within 67 hours) and evaluated their efficacy. Moreover, these values were compared between cases with and without liver cirrhosis (LC).

resultsNo significant difference was observed between antemortem and postmortem serum T-Bil levels. Although postmortem pericardial fluid T-Bil concentrations correlated with antemortem values, the pericardial fluid concentrations were significantly lower. The median postmortem pericardial fluid to antemortem serum T-Bil ratio was 0.41 ± 0.27. Although antemortem and postmortem serum T-Bil concentrations were significantly higher in the LC group than in the control group, no significant difference was observed in postmortem pericardial fluid T-Bil values.

conclusionsThis article highlights the utility of measuring serum and pericardial fluid T-Bil levels postmortem. To the best of our knowledge, this study is the first to evaluate the postmortem pericardial fluid to antemortem serum T-Bil ratio. Our results showed that this ratio was close to that reported in living patients. Therefore, postmortem pericardial fluid may serve as a significant alternative sampling source in cases where serum is unavailable. However, further evaluation of its diagnostic efficacy in LC is warranted.

Indexed as

antemortembiochemical markersforensic medicinepostmortemtotal bilirubin

Identifiers

PMID40104474
PMCPMC11917459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.